Insider · CIK 0001457477

Hallal David

Reports to the SEC for 5 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001457477

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-21	SRRKScholar Rock Holding CorpG Gift	Director, Chief Executive Officer	GGift	−36.7K sh	—	—	1,602,382
2026-06-03	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2026-04-16	SRRKScholar Rock Holding CorpS Sale	Director, Chief Executive Officer	SSale	−30.6K sh	$49.57	−$1.52M	1,639,034
2026-02-09	SRRKScholar Rock Holding CorpA Award	Director, Chief Executive Officer	AAward	+128K sh	—	—	1,669,649
2026-01-13	SRRKScholar Rock Holding CorpS Sale	Director, Chief Executive Officer	SSale	−57.5K sh	$42.70	−$2.45M	1,541,645
2025-10-08	SRRKScholar Rock Holding CorpG Gift	Director, Chief Executive Officer	GGift	−205K sh	—	—	1,599,095
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25.1K sh	—	—	0
2025-08-29	iTeos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−146K sh	—	—	0
2025-06-06	iTeos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+38.2K sh	$4.30	+$164K	38,228
2025-06-06	iTeos Therapeutics, Inc.S Sale	Director	SSale	−38.2K sh	$10.24	−$391K	0
2025-06-06	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−38.2K sh	—	—	0
2025-06-05	iTeos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+38.2K sh	$4.30	+$164K	38,227
2025-06-05	iTeos Therapeutics, Inc.S Sale	Director	SSale	−38.2K sh	$10.15	−$388K	0
2025-06-05	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−38.2K sh	—	—	38,228
2025-06-04	iTeos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+38.2K sh	$4.30	+$164K	38,227
2025-06-04	iTeos Therapeutics, Inc.S Sale	Director	SSale	−38.2K sh	$10.07	−$385K	0
2025-06-04	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−38.2K sh	—	—	76,455
2025-05-02	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+275K sh	—	—	275,167
2025-04-27	SRRKScholar Rock Holding CorpA Award	Director, Chief Executive Officer	AAward	+250K sh	—	—	554,095
2025-04-27	SRRKScholar Rock Holding CorpA Award	Director, Chief Executive Officer	AAward	+1.25M sh	—	—	1,804,095
2025-04-10	KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18K sh	—	—	18,000
2024-06-27	SRRKScholar Rock Holding CorpA Award	Director, Chief Executive Officer	AAward	+13.5K sh	—	—	304,095
2024-06-27	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+18K sh	—	—	18,000
2024-06-12	SEERSeer, Inc.A Award	Director	AAward	+58.2K sh	—	—	355,128
2024-06-11	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+24.2K sh	—	—	24,200
2024-06-06	KLRSKalaris Therapeutics, Inc.A Award	Director	AAward	+35K sh	—	—	2,143,662
2023-06-21	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+36K sh	—	—	36,000
2023-06-14	SEERSeer, Inc.A Award	Director	AAward	+23.4K sh	—	—	296,950
2023-06-14	SEERSeer, Inc. · Stock Option (right to buy)A Award	Director	AAward	+34.7K sh	—	—	34,735
2023-06-13	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+22.4K sh	—	—	22,383
2023-05-11	KLRSKalaris Therapeutics, Inc.A Award	Director	AAward	+35K sh	—	—	2,108,662
2022-10-19	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−600K sh	$8.45	−$5.07M	138,153
2022-09-29	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−400K sh	$7.35	−$2.94M	720,965
2022-07-28	KLRSKalaris Therapeutics, Inc.A Award	Director	AAward	+3.25M sh	$4.61	+$15M	16,674,766
2022-07-21	KLRSKalaris Therapeutics, Inc.S Sale	Director	SSale	−4,227 sh	$5.33	−$22.5K	2,073,662
2022-06-16	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+14K sh	—	—	14,000
2022-06-15	SEERSeer, Inc.A Award	Director	AAward	+9,945 sh	—	—	273,507
2022-06-15	SEERSeer, Inc. · Stock Option (right to buy)A Award	Director	AAward	+29.6K sh	—	—	29,640
2022-06-09	iTeos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,171 sh	$4.23	+$4,953.33	1,171
2022-06-09	iTeos Therapeutics, Inc.S Sale	Director	SSale	−1,171 sh	$19.51	−$22.8K	0
2022-06-09	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,171 sh	—	—	146,160
2022-06-09	iTeos Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,538
2022-06-08	iTeos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+5,968 sh	$4.23	+$25.2K	5,968
2022-06-08	iTeos Therapeutics, Inc.S Sale	Director	SSale	−5,968 sh	$20.39	−$122K	0
2022-06-08	iTeos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.9K sh	$2.95	+$35.1K	11,899
2022-06-08	iTeos Therapeutics, Inc.S Sale	Director	SSale	−11.9K sh	$20.39	−$243K	0
2022-06-08	iTeos Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+10.6K sh	$4.23	+$44.7K	10,577
2022-06-08	iTeos Therapeutics, Inc.S Sale	Director	SSale	−10.6K sh	$19.86	−$210K	0
2022-06-08	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,968 sh	—	—	157,908
2022-06-08	iTeos Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.9K sh	—	—	25,140

Recent filings

Accepted (ET)
Sep 234
Hallal David0001104659-26-110006
SEC(opens sec.gov)
Jun 44
Hallal David0001193125-26-257494
SEC(opens sec.gov)
Apr 204
Hallal David0001104659-26-045581
SEC(opens sec.gov)
Feb 114
Hallal David0001104659-26-013580
SEC(opens sec.gov)
Jan 154
Hallal David0001104659-26-004221
SEC(opens sec.gov)
Oct 94
Hallal David0001457477-25-000004
SEC(opens sec.gov)
Aug 294
Hallal David0001193125-25-192818
SEC(opens sec.gov)
Jun 64
Hallal David0000950170-25-083410
SEC(opens sec.gov)
May 64
Hallal David0001104659-25-045112
SEC(opens sec.gov)
Apr 294
Hallal David0001104659-25-041457
SEC(opens sec.gov)

Companies

Address

301 BINNEY STREET

CAMBRIDGE, MA, 02142